Evaluating placental and uterine muscle thickness to predict postpartum blood loss
Evaluating Placental Thickness and Thickness of Uterine Muscle at Placenta Attachment in Prediction of Postpartum Blood Loss
Benha University · NCT06351969
This study is testing if measuring the thickness of the placenta and uterine muscle can help identify women at risk for heavy bleeding after childbirth.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 150 (estimated) |
| Ages | 18 Years to 50 Years |
| Sex | Female |
| Sponsor | Benha University (other) |
| Locations | 1 site (Banhā) |
| Trial ID | NCT06351969 on ClinicalTrials.gov |
What this trial studies
This observational study aims to determine the significance of placental thickness and the thickness of the uterine muscle layer at the site of placenta attachment in predicting postpartum hemorrhage (PPH). By assessing these parameters, the study seeks to identify high-risk patients who may experience severe bleeding after delivery. The research highlights the importance of early identification of risk factors for PPH, which is a leading cause of maternal morbidity and mortality worldwide. The study will involve term pregnancies with a single viable fetus and will exclude patients with certain hematological and uterine conditions.
Who should consider this trial
Good fit: Ideal candidates for this study are pregnant women at term with a single viable fetus.
Not a fit: Patients with severe hematological disorders, uterine anomalies, or a history of postpartum hemorrhage may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved prediction and prevention of postpartum hemorrhage, ultimately reducing maternal morbidity and mortality.
How similar studies have performed: While the correlation between placental attachment and postpartum hemorrhage is not well-studied, similar approaches in assessing risk factors for PPH have shown promise in other research.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Term pregnancy (37 wk gastation and more ) * Single viable fetus Exclusion Criteria: * Severe hematological disorders that could cause abnormal coagulation * Placental implantation abnormalities or placental abruption * Uterine anomalies, including congenital or acquired structural abnormalities. * Previous history of PPH * category 1 CS and category 2 CS * Multiple pregnancy * Preterm labour * IUFD
Where this trial is running
Banhā
- Benha Univeristy — Banhā, Egypt (RECRUITING)
Study contacts
- Study coordinator: Ahmed Abdelsalam Ahmed, resident
- Email: ahmedupwork42@gmail.com
- Phone: +201065832720
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Post Partum Hemorrhage, placental thickness, uterine muscle thickness, cesarean section, vaginal delivery